Position in RVMD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,463,332
New position
Shares Held
66,461
first reported quarter
Ownership
0.031%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Korea Investment CORP holds $256,163,456 across 7 Biotechnology names. RVMD ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
201,168 | $89,829,558 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
200,321 | $66,280,209 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
73,063 | $56,451,396 | |
| 4 | INCY |
Incyte Corp
|
220,926 | $20,793,555 | |
| 5 | RPRX |
Royalty Pharma plc
|
219,972 | $10,552,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
This page
|
66,461 | $6,463,332 | |
| 7 | INSM |
INSMED Inc
|
35,429 | $5,793,350 |
All Filings in RVMD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,463,332 | 66,461 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||